Literature DB >> 20570178

Uterine artery embolization versus abdominal myomectomy: a long-term clinical outcome comparison.

Anand Narayan1, Adrea S Lee, George P Kuo, Neil Powe, Hyun S Kim.   

Abstract

PURPOSE: To assess long-term clinical effectiveness of uterine artery embolization (UAE) compared with abdominal myomectomy.
MATERIALS AND METHODS: Women who received UAE (n = 87) or abdominal myomectomy (n = 98) for symptomatic uterine leiomyomata between 2000 and 2002 at a single institution were consecutively enrolled in this study. Patients whose procedures were performed within 5 years before the study were included. Symptom evaluations with symptom severity scores, pregnancy rates, and satisfaction with the procedures were obtained via institutional review board-approved questionnaires. Chart reviews were performed to supplement analyses.
RESULTS: The retrospective cohort included 185 patients, of whom long-term follow-up was completed by 89 patients (48.1%), 48 being treated with UAE, and 41 with myomectomy. Follow-up ranged from 50 to 83 months. A higher but not statistically significant number of patients received repeat interventions after abdominal myomectomy (14%) versus UAE (8%; P = .204). Significantly higher symptom severity score improvements were seen in patients treated with UAE versus abdominal myomectomy (34 vs 31; P = .02). UAE recipients were less likely to attempt to get pregnant (P = .02), but those who did had a 66.7% success rate compared with 58.8% for patients who underwent myomectomy. Similar numbers of patients between groups were satisfied with the procedure (P = .57), reported effectiveness of symptom relief (P = .43), and would recommend the procedure to others (P = .37).
CONCLUSIONS: UAE results in long-term clinical success with outcomes comparable or superior to those of abdominal myomectomy. Copyright 2010 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20570178      PMCID: PMC2900435          DOI: 10.1016/j.jvir.2010.03.012

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  18 in total

1.  Age-related prevalence of sonographicaly confirmed uterine myomas.

Authors:  S Lurie; I Piper; I Woliovitch; M Glezerman
Journal:  J Obstet Gynaecol       Date:  2005-01       Impact factor: 1.246

2.  Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example.

Authors:  Geert J M G van der Heijden; A Rogier T Donders; Theo Stijnen; Karel G M Moons
Journal:  J Clin Epidemiol       Date:  2006-07-11       Impact factor: 6.437

3.  Evaluation of software for multiple imputation of semi-continuous data.

Authors:  L-M Yu; Andrea Burton; Oliver Rivero-Arias
Journal:  Stat Methods Med Res       Date:  2007-06       Impact factor: 3.021

4.  The direct and indirect cost burden of clinically significant and symptomatic uterine fibroids.

Authors:  David W Lee; Ronald J Ozminkowski; Ginger Smith Carls; Shaohung Wang; Teresa B Gibson; Elizabeth A Stewart
Journal:  J Occup Environ Med       Date:  2007-05       Impact factor: 2.162

5.  Effects of utero-ovarian anastomoses on clinical outcomes and repeat intervention rates after uterine artery embolization.

Authors:  Hyun S Kim; Jason Tsai; Ajanta Patra; Judy M Lee; John G Griffith; Edward E Wallach
Journal:  J Vasc Interv Radiol       Date:  2006-05       Impact factor: 3.464

6.  The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata.

Authors:  James B Spies; Karin Coyne; Noureddine Guaou Guaou; Deneane Boyle; Kerry Skyrnarz-Murphy; Sheila M Gonzalves
Journal:  Obstet Gynecol       Date:  2002-02       Impact factor: 7.661

7.  A prospective multicenter comparative study between myomectomy and uterine artery embolization with polyvinyl alcohol microspheres: long-term clinical outcomes in patients with symptomatic uterine fibroids.

Authors:  Gary P Siskin; Richard D Shlansky-Goldberg; Scott C Goodwin; Keith Sterling; John C Lipman; John L Nosher; Robert L Worthington-Kirsch; Theodore P Chambers
Journal:  J Vasc Interv Radiol       Date:  2006-08       Impact factor: 3.464

8.  Abdominal myomectomy versus uterine fibroid embolization in the treatment of symptomatic uterine leiomyomas.

Authors:  Mahmood K Razavi; Gloria Hwang; Ayda Jahed; Shohreh Modanlou; Shohreh Modanloo; Bertha Chen
Journal:  AJR Am J Roentgenol       Date:  2003-06       Impact factor: 3.959

Review 9.  Uterine fibroid tumors: diagnosis and treatment.

Authors:  Patricia Evans; Susan Brunsell
Journal:  Am Fam Physician       Date:  2007-05-15       Impact factor: 3.292

10.  Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy.

Authors:  Michal Mara; Jana Maskova; Zuzana Fucikova; David Kuzel; Tomas Belsan; Ondrej Sosna
Journal:  Cardiovasc Intervent Radiol       Date:  2007-10-18       Impact factor: 2.740

View more
  11 in total

Review 1.  Current evidence on uterine embolization for fibroids.

Authors:  James B Spies
Journal:  Semin Intervent Radiol       Date:  2013-12       Impact factor: 1.513

Review 2.  A Systematic Review of Minimally Invasive Treatments for Uterine Fibroid-Related Bleeding.

Authors:  Jiahui Zhang; Virginia-Arlene Go; Jaime Friel Blanck; Bhuchitra Singh
Journal:  Reprod Sci       Date:  2021-09-03       Impact factor: 2.924

3.  Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT.

Authors:  Jane Daniels; Lee J Middleton; Versha Cheed; William McKinnon; Dikshyanta Rana; Fusun Sirkeci; Isaac Manyonda; Anna-Maria Belli; Mary Ann Lumsden; Jonathan Moss; Olivia Wu; Klim McPherson
Journal:  Health Technol Assess       Date:  2022-04       Impact factor: 4.106

4.  Fertility after uterine artery embolization for symptomatic multiple fibroids with no other infertility factors.

Authors:  Antoine Torre; Arnaud Fauconnier; Vanessa Kahn; Olivier Limot; Laurence Bussierres; Jean Pierre Pelage
Journal:  Eur Radiol       Date:  2016-12-13       Impact factor: 5.315

5.  Cost-effectiveness of uterine-preserving procedures for the treatment of uterine fibroid symptoms in the USA.

Authors:  Anne H Cain-Nielsen; James P Moriarty; Elizabeth A Stewart; Bijan J Borah
Journal:  J Comp Eff Res       Date:  2014-05-30       Impact factor: 1.744

6.  Comparative Effectiveness of Uterine Leiomyoma Procedures Using a Large Insurance Claims Database.

Authors:  Bijan J Borah; Xiaoxi Yao; Shannon K Laughlin-Tommaso; Herbert C Heien; Elizabeth A Stewart
Journal:  Obstet Gynecol       Date:  2017-11       Impact factor: 7.661

7.  Effects of the intermittent injection with super-low pressure on the postoperative pain control during the uterine artery embolization for uterine myoma.

Authors:  Jian-Bo Zhao; Ze-Long Luo; Chao Feng; Qing-Le Zeng; Xiao-Feng He; Yan-Hao Li; Yong Chen
Journal:  Int J Clin Exp Med       Date:  2015-08-15

8.  Cost and Distribution of Hysterectomy and Uterine Artery Embolization in the United States: Regional/Rural/Urban Disparities.

Authors:  Marquisette Glass Lewis; Olúgbémiga T Ekúndayò
Journal:  Med Sci (Basel)       Date:  2017-05-16

Review 9.  Symptomatic Fibroid Management: Systematic Review of the Literature.

Authors:  Yelena Havryliuk; Robert Setton; John J Carlow; Barry D Shaktman
Journal:  JSLS       Date:  2017 Jul-Sep       Impact factor: 2.172

10.  Reintervention Rates After Myomectomy, Endometrial Ablation, and Uterine Artery Embolization for Patients with Uterine Fibroids.

Authors:  Matthew R Davis; Ahmed M Soliman; Jane Castelli-Haley; Michael C Snabes; Eric S Surrey
Journal:  J Womens Health (Larchmt)       Date:  2018-08-07       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.